Protara Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
It's my pleasure to introduce our next presenting company today, Protara. Presenting for Protara is Jesse Shefferman, CEO. Jesse, I will give the floor to you. And look forward to hopefully asking some questions at the end, but thanks again for joining us at the conference today.
Sure thing, Matt, and thank you for having us. Really appreciate the opportunity to speak to the folks here at the conference.
Let me start with a little introduction on Protara. For some, it will be a reintroduction, but I'd like to reorient the listening audience to sort of who we are and what makes us maybe particularly different from a number of other drug development companies out there today.
So Protara Therapeutics is a drug development company. We are focused on mid- to late-stage drug development in the field of oncology and rare disease. We take a particularly interesting approach, in that, what we try to do and where we find
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
